Philip Morris considers selling stake in pharmaceuticals unit to boost healthcare division

The company’s wellness division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options.

Previous post The Tell: Bank of America strategist becomes latest on Wall Street to raise S&P 500 target
Next post Kraft recalls 84,000 cases of American cheese slices over choking hazard